Jarrod P. Holmes

Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients

EA Mittendorf, Guy T. Clifton, Jarrod P. Holmes et al. · Annals of Oncology · 2014 · 240 citations · Full text

Vaccination, Vaccinology, Oncology +11

Combined Clinical Trial Results of a HER2/<i>neu</i>(E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02

George E. Peoples, Jarrod P. Holmes, Matthew T. Hueman et al. · Clinical Cancer Research · 2008 · 179 citations

Clinical trial results of the HER‐2/<i>neu</i> (E75) vaccine to prevent breast cancer recurrence in high‐risk patients

Elizabeth A. Mittendorf, Guy T. Clifton, Jarrod P. Holmes et al. · Cancer · 2011 · 170 citations · Full text

Results of the First Phase I Clinical Trial of the Novel Ii-Key Hybrid Preventive HER-2/<i>neu</i>Peptide (AE37) Vaccine

Jarrod P. Holmes, Linda C. Benavides, Jeremy D. Gates et al. · Journal of Clinical Oncology · 2008 · 136 citations

The Impact of HER2/<i>neu</i>Expression Level on Response to the E75 Vaccine: From U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02

Linda C. Benavides, Jeremy D. Gates, Mark G. Carmichael et al. · Clinical Cancer Research · 2009 · 116 citations